analysts and calls -- ML | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
analysts and calls -- ML

An SI Board Since September 2002

Posts	SubjectMarks	Bans
238	19	0

Emcee: scaram(o)uche	Type: Moderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
238	Doesn't seem to be a GENZ thread GENZYME (GENZ, US$75.1, C-1-9) Diverse pro	tom pope	-	9/7/2008
237	Thanks Tom. Always nice to know what ML is saying...	fred hayes	-	5/9/2008
236	AFFY (sell) EMEA to assess safety of EPO use in oncology The announcement that	tom pope	-	5/9/2008
235	You betcha Tom. Would like to at least read the ARNA and AFFX stuff. Thanks for	fred hayes	-	5/9/2008
234	Whole bunch of recent Merrill reports which I'll post on the subject threads	tom pope	-	5/9/2008
233	They stick to their guns and blow off the news. I see their price objective is n	tom pope	-	7/4/2007
232	Altus near the bottom of its range (low in early June) ~$12 and yesterday an 8-K	tuck	-	7/4/2007
231	ML on pharma: Industry/Sector Updates US Major Pharmaceuticals: Quarterly upsid	tom pope	-	6/29/2007
230	GENZ has been added to ML's "U.S.1" list	tom pope	-	6/4/2007
229	Industry/Sector Updates U.S. Major Pharmaceuticals We believe that strength of 1	tom pope	-	5/10/2007
228	Sorry, I missed that one. Actual text adds very little to what you posted.	tom pope	-	4/1/2007
227	ML says Vertex (VRTX) sell-off overdone, buy April 30 calls ahead of EASL: nota	tuck	-	4/1/2007
226	BioMarin on track; raising price objective to $25 We are raising our price objec	tom pope	-	2/13/2007
225	Give Ende a call. # is 212 449 1915	tom pope	-	12/22/2006
224	Given this note from September, in which ML calls the value in the best case sce	tuck	-	12/22/2006
223	Now ML has found its opinion of CBST, having apparently lost it yesterday: Vola	tom pope	-	12/9/2006
222	Ya know, rereading the 11/27 screed, though the stock is still listed as a buy,	tom pope	-	12/8/2006
221	Weird - this is what they wrote on 11/27, reiterating Buy: October Cubicin sale	tom pope	-	12/8/2006
220	Unanswered? Deafening silence. Believe it or not, this is what I pull up for CBS	tom pope	-	12/8/2006
219	Piper downgraded Cubist today, and the stock is taking it seriously. Is Merrill	tuck	-	12/8/2006
218	Merrill's stock of the week: The damn thing wouldn't copy, anyway it	tom pope	-	10/9/2006
217	Cardiology Update: Drug Eluting Stents (DES) Risk: Downgrading BSX (& Lower	tom pope	-	10/3/2006
216	<i>Aren't they the Adderal part of the equation that the ML note refer	CapitalistHogg™	-	9/25/2006
215	Aren't they the Adderal part of the equation that the ML note refers to? I	tom pope	-	9/25/2006
214	<i>Final approval may be contingent on scheduling, which may be proposed b	CapitalistHogg™	-	9/25/2006

Go to reply# or date (mm/dd/yy):